Dementia remains one of the most pressing public health challenges of our time. Its economic burden exceeds $1 trillion ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

New research suggests that commonly used medications like antibiotics, antivirals, and anti-inflammatories could lower the ...

ATx has created groundbreaking drugs for dementia and Alzheimer’s. The Icelandic startup just raised €26mn to advance the ...

As research continues, those involved say this would be a game changer, especially for patients with very limited options.

Researchers in Scotland are developing a digital tool powered by artificial intelligence that can gauge your risk of ...

By 2060, new dementia cases per year could double to one million because of the growing population of older Americans, a ...

Discover how a groundbreaking cognitive assessment tool is transforming early dementia detection with 99.9% accuracy and what ...

Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...

The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...